Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of 11-oxygenated Androgens in Androgen Excess and Metabolic Dysfunction of Women With Polycystic Ovary Syndrome

NCT05246865 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT05246865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05246865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of 11-oxygenated Androgens in Androgen Excess and Metabolic Dysfunction of Women With Polycystic Ovary Syndrome
Lead sponsor
University of Birmingham
Phase
Not applicable
Overall status
Unknown status
Start date
October 10, 2021
Completion date
May 30, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polycystic ovary syndrome